Abbott Laboratories (TSX:ABT)
Canada · Delayed Price · Currency is CAD 18.52
+0.32 (1.76%)
Oct 30, 2026, 3:49 PM EDT
Abbott Laboratories Employees
Abbott Laboratories had 122,000 employees as of September 30, 2026. The number of employees increased by 7,000 or 6.09% since the number was reported on December 31, 2025.
Employees
122,000
Change
7,000
Growth
6.09%
Revenue / Employee
595.38K CAD
Profits / Employee
57.74K CAD
Market Cap
256.41B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2026 | 122,000 | 7,000 | 6.09% |
| Dec 31, 2025 | 115,000 | 1,000 | 0.88% |
| Dec 31, 2024 | 114,000 | 0 | - |
| Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
| Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Abbott Laboratories News
- 46 minutes ago - Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System - PRNewsWire
- 2 days ago - FDA posts adverse event report for Abbott’s Tendril SDX - TheFly
- 3 days ago - Abbott initiates pivotal trial for Cephea device - TheFly
- 3 days ago - Abbott initiates pivotal trial for Cephea™ device, an innovative treatment for mitral heart valve disease - PRNewsWire
- 5 days ago - Abbott cut to Hold at Argus amid reimbursement uncertainty, competitive pressure - TheFly
- 5 days ago - Abbott downgraded to Hold from Buy at Argus - TheFly
- 6 days ago - Abbott announces commercial availability of Oncodetect residual disease test - TheFly
- 6 days ago - Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment - PRNewsWire